Neuropeptides Drive Immune Tolerance by Generating Regulatory T Cells
Neuropeptides (VIP, alpha-MSH, CGRP) promote immune tolerance by generating regulatory T cells and suppressing inflammatory responses — a novel neuroimmune pathway for controlling autoimmunity and transplant rejection.
Quick Facts
What This Study Found
Neuropeptides including VIP, alpha-MSH/KPV, and CGRP promote immune tolerance through generation of regulatory T cells (Tregs) and suppression of pro-inflammatory dendritic cell activation — a novel immunosuppressive pathway with therapeutic potential for autoimmunity and transplantation.
Key Numbers
How They Did This
review study on neuropeptides, immune-function.
Why This Research Matters
Relevant for neuropeptides, immune-function, inflammation.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Neuropeptides including VIP, alpha-MSH/KPV, and CGRP promote immune tolerance through generation of regulatory T cells (Tregs) and suppression of pro-
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2006.
- Original Title:
- A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.
- Published In:
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 1(4), 400-9 (2006)
- Authors:
- Ganea, Doina(4), Gonzalez-Rey, Elena(7), Delgado, Mario(10)
- Database ID:
- RPEP-01137
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Neuropeptides Drive Immune Tolerance by Generating Regulatory T Cells
What was found?
Neuropeptides (VIP, alpha-MSH, CGRP) promote immune tolerance by generating regulatory T cells and suppressing inflammatory responses — a novel neuroimmune pathway for controlling autoimmunity and transplant rejection.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01137APA
Ganea, Doina; Gonzalez-Rey, Elena; Delgado, Mario. (2006). A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 1(4), 400-9.
MLA
Ganea, Doina, et al. "A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.." Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2006.
RethinkPeptides
RethinkPeptides Research Database. "A novel mechanism for immunosuppression: from neuropeptides ..." RPEP-01137. Retrieved from https://rethinkpeptides.com/research/ganea-2006-a-novel-mechanism-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.